Effect of PRP on the Therapy for Hair Growth
Primary Purpose
Hair Loss/Baldness
Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
hair loss, baldness (patient's own platelet-rich plasma)
Sponsored by
About this trial
This is an interventional treatment trial for Hair Loss/Baldness
Eligibility Criteria
Inclusion Criteria:
- patient with hair loss/baldness
- age of 20-70 years old
Exclusion Criteria:
- patient with systemic disorder
- phyco
- patient with coagulation abnormality
- patient with inflammation
Sites / Locations
- China Medical University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
platelet-rich plasma
Arm Description
hair loss, baldness
Outcomes
Primary Outcome Measures
examination the effect of PRP on hair loss/baldness
We will track and evaluate regularly the effect and efficiency of PRP on human hair growing density and newly-formed hair length by phtography and measurement.
Secondary Outcome Measures
Full Information
NCT ID
NCT02087319
First Posted
March 12, 2014
Last Updated
February 29, 2016
Sponsor
China Medical University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02087319
Brief Title
Effect of PRP on the Therapy for Hair Growth
Official Title
Application and Evaluation of PRP on the Therapy for Hair Loss Disorder
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
January 2014 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
China Medical University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of study is to examine the advantage of PRP on hair loss and male pattern baldness. The investigators will inject PRP into the scalp regions where with little or no hair, and evaluate the effect and efficiency of PRP on human hair growth.
Detailed Description
Hair loss is a disorder in which the hair undergoes aberration growth cycles and falls out from scalp. A number of factors like hormones, genetic factors, diet, endocrine abnormalities, systemic illnesses, drug intake, and hair shaft abnormalities may cause hair loss. Androgen alopecia or male pattern baldness is the most common cause of hair loss caused by progressive shortening of the anagen and increased number of hair follicles in telogen, which has a significant influence on psychological distress.
Except medical treatment and baldness surgery, a new interest in treating hair loss and baldness has been stimulated by using platelet plasma growth factors obtained from the patient's own platelet-rich plasma (PRP). PRP is a portion of plasma fraction of autologous blood having a high concentration of thrombocytes, and can be activated by Thrombin to release multiple growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), and transforming growth factor beta (TGF-β). PRP is known for the capacity to stimulate cell proliferation and differentiation. The action of platelet plasma growth factors on the development of hair follicles has already been established. PRP has also been shown to increase the yield of implanted follicular units during male baldness surgery.
Our study will focus on the advantage of PRP for the treatment of hair loss and male pattern baldness. PRP from autologous blood can be mixed with thrombin in appropriate ratio and inject into the regions on scalp which is interested. We will track and evaluate regularly the effect and efficiency of PRP on human hair growth.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hair Loss/Baldness
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
platelet-rich plasma
Arm Type
Experimental
Arm Description
hair loss, baldness
Intervention Type
Other
Intervention Name(s)
hair loss, baldness (patient's own platelet-rich plasma)
Intervention Description
hair loss, baldness
Primary Outcome Measure Information:
Title
examination the effect of PRP on hair loss/baldness
Description
We will track and evaluate regularly the effect and efficiency of PRP on human hair growing density and newly-formed hair length by phtography and measurement.
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient with hair loss/baldness
age of 20-70 years old
Exclusion Criteria:
patient with systemic disorder
phyco
patient with coagulation abnormality
patient with inflammation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeng Long-Bin
Organizational Affiliation
organ transplantation center
Official's Role
Study Chair
Facility Information:
Facility Name
China Medical University Hospital
City
Taichung
Country
Taiwan
12. IPD Sharing Statement
Learn more about this trial
Effect of PRP on the Therapy for Hair Growth
We'll reach out to this number within 24 hrs